Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3751 AL 3765

Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases

Ngoungoure VL, Schluesener J, Moundipa PF, Schluesener H.

Mol Nutr Food Res. 2015 Jan;59(1):8-20. doi: 10.1002/mnfr.201400290. Epub 2014 Oct 9.

Diagnostic genetic testing for Huntington's disease

Craufurd D, MacLeod R, Frontali M, Quarrell O, Bijlsma EK, Davis M, Hjermind LE, Lahiri N, Mandich P, Martinez A, Tibben A, Roos RA; Working Group on Genetic Counselling and Testing of the European Huntington's Disease Network (EHDN).

Pract Neurol. 2015 Feb;15(1):80-4. doi: 10.1136/practneurol-2013-000790. Epub 2014 Aug 28.

A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease

Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):124-6. doi: 10.3109/21678421.2014.952238. Epub 2014 Sep 10.

Sydenham Chorea and PANDAS in South Africa: Review of Evidence and Recommendations for Management in Resource-Poor Countries

Walker KG, de Vries PJ, Stein DJ, Wilmshurst JM.

J Child Neurol. 2015 Jun;30(7):850-9. doi: 10.1177/0883073814544704. Epub 2014 Sep 16.

The psychological impact of predictive genetic testing for Huntington's disease: a systematic review of the literature

Crozier S, Robertson N, Dale M.

J Genet Couns. 2015 Feb;24(1):29-39. doi: 10.1007/s10897-014-9755-y. Epub 2014 Sep 20.

C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population

Koutsis G, Karadima G, Kartanou C, Kladi A, Panas M.

Neurobiol Aging. 2015 Jan;36(1):547.e13-6. doi: 10.1016/j.neurobiolaging.2014.08.020. Epub 2014 Aug 27.

Parkinson's disease: chameleons and mimics

Ali K, Morris HR.

Pract Neurol. 2015 Feb;15(1):14-25. doi: 10.1136/practneurol-2014-000849. Epub 2014 Sep 24.

Delivering a disease-modifying treatment for Huntington's disease

Godinho BM, Malhotra M, O'Driscoll CM, Cryan JF.

Drug Discov Today. 2015 Jan;20(1):50-64. doi: 10.1016/j.drudis.2014.09.011. Epub 2014 Sep 26.

An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders

Yang Y, Jiang S, Yan J, Li Y, Xin Z, Lin Y, Qu Y.

Cytokine Growth Factor Rev. 2015 Feb;26(1):47-57. doi: 10.1016/j.cytogfr.2014.09.002. Epub 2014 Sep 16.

A phase II study of laquinimod in Crohn's disease

D'Haens G, Sandborn WJ, Colombel JF, Rutgeerts P, Brown K, Barkay H, Sakov A, Haviv A, Feagan BG; Laquinimod for Crohn's Disease Investigators.

Gut. 2015 Aug;64(8):1227-35. doi: 10.1136/gutjnl-2014-307118. Epub 2014 Oct 3.

Autophagy in Huntington disease and huntingtin in autophagy

Martin DD, Ladha S, Ehrnhoefer DE, Hayden MR.

Trends Neurosci. 2015 Jan;38(1):26-35. doi: 10.1016/j.tins.2014.09.003. Epub 2014 Oct 2.

Challenges of Huntington's disease and quest for therapeutic biomarkers

Kotrcova E, Jarkovska K, Valekova I, Zizkova M, Motlik J, Gadher SJ, Kovarova H.

Proteomics Clin Appl. 2015 Feb;9(1-2):147-58. doi: 10.1002/prca.201400073. Epub 2014 Nov 2.

Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases

Pratt WB, Gestwicki JE, Osawa Y, Lieberman AP.

Annu Rev Pharmacol Toxicol. 2015;55:353-71. doi: 10.1146/annurev-pharmtox-010814-124332. Epub 2014 Sep 25.

Post-infectious autoimmune disorders: Sydenham's chorea, PANDAS and beyond

Williams KA, Swedo SE.

Brain Res. 2015 Aug 18;1617:144-54. doi: 10.1016/j.brainres.2014.09.071. Epub 2014 Oct 7.

The N170 and face perception in psychiatric and neurological disorders: A systematic review

Feuerriegel D, Churches O, Hofmann J, Keage HAD.

Clin Neurophysiol. 2015 Jun;126(6):1141-1158. doi: 10.1016/j.clinph.2014.09.015. Epub 2014 Sep 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias